Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Obesity01:24

Obesity

1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

440
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
440
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

324
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
324
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

30
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
30
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

28
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
28
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

26
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
26

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Abstracts International Scientific Day on Oxidative Stress, Aging, and Age-Related Diseases.

La Tunisie medicale·2026
Same author

STSM 2025 & 2nd African Medical Writing Congress.

La Tunisie medicale·2026
Same author

OVERWEIGHT AMONG TUNISIAN SCHOOL-AGED CHILDREN: PREVALENCE AND ASSOCIATED FACTORS.

Georgian medical news·2026
Same author

[Estimation of sodium intake in type 2 diabetic patients: Comparative study of Exsel test and 24-hour natriuresis].

Annales de cardiologie et d'angeiologie·2026
Same author

INTERMITTENT FASTING (5:2) VS. NON-FASTING: A COMPARATIVE ANALYSIS OF ANTHROPOMETRIC PARAMETERS, DEPRESSION, AND STRESS IN HEALTHY ADULTS - A CROSS-SECTIONAL STUDY.

Georgian medical news·2025
Same author

2022 TUNISIAN NATIONAL CONGRESS OF MEDICINE ABSTRACTS.

La Tunisie medicale·2023

Related Experiment Video

Updated: May 3, 2026

An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

1.8K

OBESITY AND THYROID FUNCTION IN OBESE WOMEN: A PILOT STUDY.

C Jemai1, R Gharbi2, H Kandara2

  • 11Faculty of Medicine of Tunis; 2National Institute of Nutrition of Tunis, Department C, Tunisia.

Georgian Medical News
|March 30, 2025
PubMed
Summary

This study in obese women found that free thyroxine (FT4) levels, not thyroid stimulating hormone (TSH), correlated with cardiometabolic risk factors. These findings highlight FT4

More Related Videos

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.5K
Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study
03:05

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

741

Related Experiment Videos

Last Updated: May 3, 2026

An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

1.8K
Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.5K
Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study
03:05

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

741

Area of Science:

  • Endocrinology
  • Metabolic Health
  • Obesity Research

Background:

  • Obesity is a growing global health concern, particularly in Tunisia.
  • Thyroid dysfunction is common in obese individuals.
  • Understanding the relationship between thyroid status and metabolic health in obesity is crucial.

Purpose of the Study:

  • To assess thyroid function in a cohort of obese Tunisian women.
  • To investigate the association between thyroid status parameters (FT4, TSH) and clinical/metabolic factors.
  • To explore correlations with body composition, insulin resistance, and lipid profiles.

Main Methods:

  • Cross-sectional retrospective study of 50 obese women.
  • Collected data included Body Mass Index (BMI), waist circumference (WC), fasting glycemia, insulinemia, lipid profile, and body composition via bioelectrical impedancemetry.
  • Calculated Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) and Beta-cell function (HOMA-B).

Main Results:

  • Mean BMI was 41.2±9.3 kg/m², mean body fat percentage was 43.4±7.1%.
  • 96% of participants exhibited insulin resistance.
  • Free Thyroxine (FT4) showed significant correlations with age, fasting glucose, insulinemia, cholesterol, and HDL; TSH did not correlate with cardiometabolic parameters or body fat.

Conclusions:

  • Free Thyroxine (FT4) demonstrated a stronger association with cardiometabolic risk parameters than TSH in this obese female population.
  • The findings suggest FT4 may be a more relevant marker for metabolic disturbances in obesity.
  • Further research is warranted to elucidate the specific role of FT4 in obesity-related metabolic complications.